Arcturus Therapeutics Holdings Inc. ARCT announced that the FDA has granted a Fast Track designation to its self-amplifying ...

In early 2024, the bird influenza that had been spreading across the globe for nearly three decades did something wholly ...

The outcome of years-long negotiations on a global agreement on tackling future pandemics remained in doubt ahead of a final ...

Health Secretary Kennedy, America’s top anti-vaccine zealot, tours measles-ravaged regions while cynically consoling families ...

As the bird flu outbreak continues, public health outreach to farm workers is meeting fear and resistance amid Trump’s ...

Immigration raids and threats have undermined efforts to prevent and detect bird flu infections among farmworkers, researchers say.

The new nasal vaccine only needs one dose and produces reliable immunity right at the site where the virus enters the body.

The University of Maryland and USDA Agricultural Research Service researchers have secured $648,881 to develop a nasal vaccine that can prevent H5N1 bird flu in dairy cows. The funding comes from the ...

Arcturus Therapeutics Holdings has won U.S. Food and Drug Administration fast-track designation for its ARCT-2304 pandemic flu vaccine candidate.

Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).

This isn’t just an animal health crisis — it’s a risk to public health. When animals consume foods containing live virus, ...

Last week, a judge decided to temporarily block a federal order that would have terminated $31 million in grant funding to ...